Precigen, Inc. - Common Stock (PGEN)
1.3500
-0.0100 (-0.74%)
Precigen Inc is a biotechnology company focused on developing innovative gene and cell therapies aimed at addressing a range of diseases, including cancer and genetic disorders
The company leverages its proprietary technologies to create advanced therapeutic solutions that aim to enhance the body's immune response and provide targeted treatment options. By utilizing its expertise in genetic engineering and immunology, Precigen works to bring transformative health solutions to patients while advancing the field of precision medicine.
Frequently Asked Questions
Is Precigen, Inc. - Common Stock publicly traded?
Yes, Precigen, Inc. - Common Stock is publicly traded.
What exchange does Precigen, Inc. - Common Stock trade on?
Precigen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Precigen, Inc. - Common Stock?
The ticker symbol for Precigen, Inc. - Common Stock is PGEN on the Nasdaq Stock Market
What is the current price of Precigen, Inc. - Common Stock?
The current price of Precigen, Inc. - Common Stock is 1.350
When was Precigen, Inc. - Common Stock last traded?
The last trade of Precigen, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Precigen, Inc. - Common Stock?
The market capitalization of Precigen, Inc. - Common Stock is 340.77M
How many shares of Precigen, Inc. - Common Stock are outstanding?
Precigen, Inc. - Common Stock has 252.42M shares outstanding.